Apart from proliferation, CAFs also stimulate cancer cell survival during both chemo- and radiotherapy through exosomally delivered molecules or through direct signaling, for instance via IGF1/2, CXCL12 and β-hydroxybutyrate [34–36]. Here, CXCL12 is linked to cancer.